Cargando…
Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response
In various cancer models, dietary interventions have been shown to inhibit tumor growth, improve anticancer drug efficacy, and enhance immunity, but no such evidence exists for epithelial ovarian cancer (EOC), the most lethal gynecologic cancer. The anticancer immune responses induced by 16-h interm...
Autores principales: | Udumula, Mary Priyanka, Singh, Harshit, Rashid, Faraz, Poisson, Laila, Tiwari, Nivedita, Dimitrova, Irina, Hijaz, Miriana, Gogoi, Radhika, Swenor, Margaret, Munkarah, Adnan, Giri, Shailendra, Rattan, Ramandeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562806/ https://www.ncbi.nlm.nih.gov/pubmed/37822507 http://dx.doi.org/10.1016/j.isci.2023.107839 |
Ejemplares similares
-
Intermittent Fasting induced ketogenesis inhibits mouse epithelial ovarian tumors by promoting anti-tumor T cell response
por: Udumula, Mary Priyanka, et al.
Publicado: (2023) -
A patient perspective on applying intermittent fasting in gynecologic cancer
por: Redding, Ashley, et al.
Publicado: (2023) -
Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo
por: Udumula, Mary P., et al.
Publicado: (2022) -
Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction
por: Al-Wahab, Zaid, et al.
Publicado: (2015) -
A metabolomic approach to identifying platinum resistance in ovarian cancer
por: Poisson, Laila M, et al.
Publicado: (2015)